• LAST PRICE
    0.6800
  • TODAY'S CHANGE (%)
    Trending Up0.0198 (2.9991%)
  • Bid / Lots
    0.6610/ 14
  • Ask / Lots
    0.6800/ 10
  • Open / Previous Close
    0.6500 / 0.6602
  • Day Range
    Low 0.6500
    High 0.6822
  • 52 Week Range
    Low 0.6301
    High 81.9000
  • Volume
    60,112
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.6602
TimeVolumeFWBI
09:32 ET33480.6584
09:33 ET26500.6601
09:39 ET4000.68
09:42 ET1800.6609
09:44 ET1000.6798
09:46 ET6500.6694
09:51 ET8150.66915
09:55 ET6000.662
10:02 ET1000.6694
10:13 ET15000.675
10:15 ET28870.67
10:20 ET3890.6799
10:24 ET9300.6667
10:27 ET1030.6667
10:29 ET14320.66
10:31 ET5000.6699
10:40 ET2500.660101
10:45 ET22000.67
11:02 ET11770.6655
11:03 ET1200.6611
11:05 ET5800.661
11:09 ET1000.6699
11:20 ET7000.6611
11:32 ET10000.661101
11:34 ET6000.665
11:36 ET7610.661
11:38 ET17380.665
12:03 ET3680.6584
12:06 ET9100.657499
12:12 ET10000.6595
12:14 ET1350.659
12:24 ET36000.6647
12:26 ET1000.6644
12:32 ET31500.665
12:33 ET1000.6681
12:35 ET6000.665
12:39 ET11000.6649
12:46 ET7170.6699
12:48 ET37750.6667
12:55 ET28040.68
12:57 ET17490.6689
01:00 ET30270.68
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesFWBI
First Wave BioPharma Inc
3.9M
0.0x
---
United StatesRGMP
Regnum Corp
3.9M
-4.3x
---
United StatesSCPS
Scopus Biopharma Inc
4.2M
-0.2x
---
United StatesPBLA
Panbela Therapeutics Inc
4.2M
-0.1x
---
United StatesALLR
Allarity Therapeutics Inc
4.5M
-0.1x
---
United StatesCWBR
CohBar Inc
4.5M
-0.4x
---
As of 2022-11-26

Company Information

First Wave BioPharma, Inc. is engaged in the research and development of targeted, non-systemic therapies for the treatment for gastrointestinal (GI) diseases. The Company is focused on developing its pipeline of gut-restricted GI clinical product candidates, including niclosamide, which is an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, which is a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. The Company is advancing two separate clinical programs of niclosamide formulations, both of which are in Phase II clinical trials, including FW-COV for Severe Acute Respiratory Syndrome Coronavirus 2 GI infections, and FW-UP for ulcerative proctitis and ulcerative proctosigmoiditis. The adrulipase programs is focused on the development of an oral, non-systemic, biologic capsule for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis and chronic pancreatitis.

Contact Information

Headquarters
777 Yamato Road, Suite 502BOCA RATON, FL, United States 33431
Phone
561-589-7020
Fax
---

Executives

Chairman of the Board, President, Chief Executive Officer
James Sapirstein
Chief Financial Officer
Sarah Romano
Lead Independent Director
Edward Borkowski
Director
David Hoffman
Independent Director
Charles Casamento

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.9M
Revenue (TTM)
$0.00
Shares Outstanding
5.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.75
EPS
$-35.53
Book Value
$-15.80
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.